Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
Open Access
- 1 May 1996
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 183 (5) , 2043-2051
- https://doi.org/10.1084/jem.183.5.2043
Abstract
The T cell receptor (TCR) recognizes a ligand composed of a major histocompatibility complex (MHC) molecule and a peptide antigen. Prior studies of murine T cell clones have demonstrated that residues in the CDR3 region of TCR interact with amino acids in the peptide during MHC-restricted antigen recognition. However, the questions of whether direct TCR MHC contacts are made and where such contact sites might map in the TCR have not been resolved. In this study, we have taken advantage of the promiscuous recognition of a peptide from influenza virus (HA 307-319) by human T cell clones to map sites in the TCR that mediate differences in human leukocyte antigen-D related (HLA-DR) restriction in the presence of a common peptide antigen. Site-specific mutagenesis of cloned TCR genes and transfection into Jurkat cells were used to demonstrate that single amino acid substitutions in CDR2 of the TCR-alpha chain controlled whether a T cell was restricted by the product of a single DR allele (DR7) or would respond to the HA 307-319 peptide when presented by the products of one of several different DR alleles (DR1, DR4, DR5, or DR7). Because the relevant DR alleles are defined by polymorphism in the DR-beta chain, these results also suggest a rotational orientation for recognition in which TCR-alpha interacts with DR beta.Keywords
This publication has 23 references indexed in Scilit:
- Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR moleculesHuman Immunology, 1994
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- How αβ T-cell receptors ‘see’ peptide/MHC complexesImmunology Today, 1993
- T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.The Journal of Experimental Medicine, 1993
- An MHC interaction site maps to the amino-terminal half of the T cell receptor α chain variable domainCell, 1992
- Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenicsNature, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- T-cell antigen receptor genes and T-cell recognitionNature, 1988
- Canonical structures for the hypervariable regions of immunoglobulinsJournal of Molecular Biology, 1987
- Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.The Journal of Experimental Medicine, 1984